News for Asahi Kasei Corporation (3407.T)

SET-listed PTT Global Chemical (GC) aims to shift from red to black this year by continuing its cost reduction plan amid the sluggish global petrochemical industry.

EV Battery Material Refineries - Mangrove Lithium Received $35M in Funding to Accelerate Development: Mangrove Lithium has secured $35 million in funding to develop an electric vehicle (EV) battery...

Mangrove to Supply North America’s Growing Battery Value Chain, Setting New Standards In Lithium Processing and Refining Mangrove to Supply North America’s Growing…

Rouse said AKM has observed "a significant trend" whereby health-oriented technology is being integrated into consumer electronics such as wearables.

TOKYO & NOVI, Mich. & DÜSSELDORF, Germany — Asahi Kasei Battery Separator Corporation marked a significant step in its commitment to supporting the North American …

The Dialysis Equipment Market Size sector reached a market value of USD 15,092.0 Million in 2017. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 5.5% from 2017…

The membranes market is expanding into healthcare applications, including dialysis and drug delivery systems which driving demand for advanced membrane...

Asahi Kasei stock looks quite cheap as a sum of its parts, and has been the case for years now. See why we think AHKSF could be a decent long-term value play.

Japan stocks lower at close of trade; Nikkei 225 down 2.79%

Asahi Kasei and Honda Sign Shareholders' Agreement to Convert Existing Asahi Kasei Subsidiary into Joint Venture for Production of Lithium-ion Battery Separators in Canada

Metal Replacement Market Size Was Valued at USD 183.40 Billion in 2023 and is Projected to Reach USD 408.32 Billion by 2032, Growing at a CAGR of 9.3% From...

The rise in the adoption of lightweight and fuel-efficient vehicle technologies and the surge in demand for durable and versatile materials are driving the...

Growing Demand for Packaging Solutions from Expanding e-Commerce and Consumer Industry Driving Up Flexographic Printing Technology Demand....

KYOTO, Japan, Oct. 7, 2024 /PRNewswire/ -- Rege Nephro Co., Ltd. (https://www.regenephro.co.jp/) is excited to announce that the company has successfully developed a funding plan of total 25 billion yen in new Series B funding and raised 22.5 billion yen with the first payment. This significant investment brings the company's total funding to 44 billion yen. The funding round attracted a mix of strategic investors, including DCI Partners Co., Ltd. as a lead investor, JIC Venture Growth Investments Co., Ltd., Nippon Venture Capital CO., Ltd., TOHOKU University Venture Partners Co., Ltd., Golden Asia Fund Ventures Ltd., Mitsui Chemicals, Inc., Global Brain Corporation, Kyoto University Innovation Capital Co., Ltd., JAFCO Group Co., Ltd., Mitsubishi UFJ Capital Co., Ltd., ASAHI KASEI CORPORATION, QB Capital, LLC who recognize the potential of Rege Nephro in delivering new treatments to patients suffering from their diseases. The newly acquired funds will be strategically used to advance the clinical trials of RN-014, our promising treatment in Phase II trials for Autosomal Dominant Polycystic Kidney Disease (ADPKD), and to prepare for clinical trials in the United States. Additionally, the funding will support the completion of preclinical trials for our second innovative product, RN-032, aimed at treating Chronic Kidney Disease (CKD) through cell therapy.

As per Fortune Business Insights’ report, the Continuous Renal Replacement Therapy Market share sector attained a worth of USD 1.04 Billion in 2023. Forecasts indicate a promising path, foreseeing a…

Surge in demand for synthetic fibers in the medical sector for manufacturing surgical garments, wound dressings, and medical textiles....

The Global Membrane Separation Technology Market Size was Valued at USD 28.4 Billion in 2023 and the Worldwide Membrane Separation Technology Market Size...

The high temperature market is expected to grow due to the demand for superior-performance materials across high-tech and industrial applications. The...

The defibrillator market is surged for growth in the coming years, driven by a rise in the number of sudden cardiac arrest cases as well as due to growing...